W

Wai Yuen Tong Medicine Holdings Ltd
HKEX:897

Watchlist Manager
Wai Yuen Tong Medicine Holdings Ltd
HKEX:897
Watchlist
Price: 0.38 HKD -2.56% Market Closed
Market Cap: 427.5m HKD

Wai Yuen Tong Medicine Holdings Ltd
Interest Income Expense

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Wai Yuen Tong Medicine Holdings Ltd
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
W
Wai Yuen Tong Medicine Holdings Ltd
HKEX:897
Interest Income Expense
HK$22.4m
CAGR 3-Years
N/A
CAGR 5-Years
-13%
CAGR 10-Years
-20%
G
Grand Pharmaceutical Group Ltd
HKEX:512
Interest Income Expense
HK$392.8m
CAGR 3-Years
N/A
CAGR 5-Years
54%
CAGR 10-Years
N/A
U
United Laboratories International Holdings Ltd
HKEX:3933
Interest Income Expense
ÂĄ240.7m
CAGR 3-Years
157%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sino Biopharmaceutical Ltd
HKEX:1177
Interest Income Expense
ÂĄ2.8B
CAGR 3-Years
-43%
CAGR 5-Years
49%
CAGR 10-Years
18%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Interest Income Expense
-HK$1.1B
CAGR 3-Years
5%
CAGR 5-Years
18%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Interest Income Expense
$513.2m
CAGR 3-Years
116%
CAGR 5-Years
64%
CAGR 10-Years
31%
No Stocks Found

Wai Yuen Tong Medicine Holdings Ltd
Glance View

Market Cap
445m HKD
Industry
Pharmaceuticals

Wai Yuen Tong Medicine Holdings Ltd. is an investment holding company, which engages in the production and sale of pharmaceutical products. The company employs 1,825 full-time employees The firm operates through three segments. Production and Sale of Chinese Pharmaceutical and Health Food Products segment is mainly engaged in the manufacture, processing and retailing of traditional Chinese medicine in China and Hong Kong. Its products include Chinese medicines under the brand Wai Yuen Tong, as well as products manufactured with traditional prescriptions. Production and Sale of Western Pharmaceutical and Health Food Products segment is engaged in the processing and sales of Western pharmaceutical products and personal care products under the brands Madame Pearl’s and Pearl’s. Property Investment segment is engaged in the investment in commercial properties for rental income.

Intrinsic Value
0.44 HKD
Undervaluation 13%
Intrinsic Value
Price
W

See Also

What is Wai Yuen Tong Medicine Holdings Ltd's Interest Income Expense?
Interest Income Expense
22.4m HKD

Based on the financial report for Mar 31, 2025, Wai Yuen Tong Medicine Holdings Ltd's Interest Income Expense amounts to 22.4m HKD.

What is Wai Yuen Tong Medicine Holdings Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-20%

Back to Top